Orano Receives €300 Million Cash Injection From France
The French government has injected €300 million ($330 million) into state-controlled uranium producer Orano. This capital infusion was announced on Thursday by both the company and the economy ministry.
The infusion saw Orano issue new shares which were purchased entirely by the French state, increasing its stake in the company to 90.3%. The remaining shareholders, Japan’s Nuclear Fuel Limited and Mitsubishi Heavy Industries, saw their stakes reduced from 5% to 4.8% each.
The investment is aimed at financing strategic projects, including the expansion of the Georges-Besse II enrichment plant in southern France. This extension is expected to increase Orano’s uranium enrichment capacity by one-third, a key step in a market currently dominated by Russia’s Rosatom, which holds a 43% share. Other major players include European group Urenco (31%), China’s CNNC, and Orano itself (12%).
READ: Orano to Build Multi-Billion Dollar Uranium Enrichment Plant in Tennessee
The infusion comes at a time when European countries are actively seeking to reduce their reliance on Russian energy sources, particularly following the 2022 invasion of Ukraine. Orano, formerly known as Areva, primarily enriches raw uranium from Canada and Kazakhstan, having recently ceased operations in Niger due to difficulties in reaching an agreement with the country’s new military leadership.
Orano’s statement emphasized that this capital injection reflects “a promising environment with new perspectives for nuclear energy in France and around the world to meet climate and sovereignty issues.”
Information for this story was found via Reuters, and the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
